These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11267933)

  • 1. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori.
    Tatemichi M; Kabuto M; Tsugane S
    Jpn J Cancer Res; 2001 Mar; 92(3):243-8. PubMed ID: 11267933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
    Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
    World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new modified ABCD method for gastric neoplasm screening.
    Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
    Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
    Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
    Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
    Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
    Gong Y; Wei W; Yuan Y
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
    Ohkusa T; Takashimizu I; Fujiki K; Araki A; Honda K; Shimoi K; Sakurazawa T; Horiuchi T; Suzuki S; Ariake K; Ishii K
    J Clin Gastroenterol; 1997 Jul; 25(1):317-22. PubMed ID: 9412911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; Martín de Argila C
    Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
    Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
    Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
    Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
    Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome.
    Takeoka A; Tayama J; Yamasaki H; Kobayashi M; Ogawa S; Saigo T; Hayashida M; Shirabe S
    PLoS One; 2016; 11(11):e0166588. PubMed ID: 27851820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serological Changes after Equivocal Helicobacter pylori-serology Test Findings Dependent on Gastric Secreting Ability].
    Kim JH; Lee SY; Kwon HG; Lee SP; Kim JH; Sung IK; Park HS; Shim CS
    Korean J Gastroenterol; 2017 Oct; 70(4):181-189. PubMed ID: 29060956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori.
    Tatemichi M; Iwasaki M; Sasazuki S; Tsugane S
    J Hum Genet; 2009 Oct; 54(10):557-63. PubMed ID: 19696791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
    Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.